Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol
Open Access
- 20 February 2009
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 9 (1) , 63
- https://doi.org/10.1186/1471-2458-9-63
Abstract
Background Screening invitations have traditionally been brief, providing information only about population benefits. Presenting information about the limited individual benefits and potential harms of screening to inform choice may reduce attendance, particularly in the more socially deprived. At the same time, amongst those who attend, it might increase motivation to change behavior to reduce risks. This trial assesses the impact on attendance and motivation to change behavior of an invitation that facilitates informed choices about participating in diabetes screening in general practice. Three hypotheses are tested: 1. Attendance at screening for diabetes is lower following an informed choice compared with a standard invitation. 2. There is an interaction between the type of invitation and social deprivation: attendance following an informed choice compared with a standard invitation is lower in those who are more rather than less socially deprived. 3. Amongst those who attend for screening, intentions to change behavior to reduce risks of complications in those subsequently diagnosed with diabetes are stronger following an informed choice invitation compared with a standard invitation. Method/Design 1500 people aged 40–69 years without known diabetes but at high risk are identified from four general practice registers in the east of England. 1200 participants are randomized by households to receive one of two invitations to attend for diabetes screening at their general practices. The intervention invitation is designed to facilitate informed choices, and comprises detailed information and a decision aid. A comparison invitation is based on those currently in use. Screening involves a finger-prick blood glucose test. The primary outcome is attendance for diabetes screening. The secondary outcome is intention to change health related behaviors in those attenders diagnosed with diabetes. A sample size of 1200 ensures 90% power to detect a 10% difference in attendance between arms, and in an estimated 780 attenders, 80% power to detect a 0.2 sd difference in intention between arms. Discussion The DICISION trial is a rigorous pragmatic denominator based clinical trial of an informed choice invitation to diabetes screening, which addresses some key limitations of previous trials. Trial registration Current Controlled Trials ISRCTN73125647Keywords
This publication has 71 references indexed in Scilit:
- Time orientation and health-related behaviour: Measurement in general population samplesPsychology & Health, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- How well do the theory of reasoned action and theory of planned behaviour predict intentions and attendance at screening programmes? A meta-analysisPsychology & Health, 2008
- Evaluation of an informed choice invitation for type 2 diabetes screeningPatient Education and Counseling, 2008
- Screening for and prevention of type 2 diabetesBMJ, 2008
- Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysisBMJ, 2008
- Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trialBMJ, 2007
- Patient Education on Prostate Cancer Screening and Involvement in Decision MakingAnnals of Family Medicine, 2007
- Information about screening – is it to achieve high uptake or to ensure informed choice?Health Expectations, 2001
- Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being.American Psychologist, 2000